As well, the loss or inhibition of OGG1 and subsequent accumulation of 8-oxodG in the genome are associated with cancer, neurodegenerative diseases, metabolic diseases, obesity, and autism [22, 29, 31, 32]. Here, OGG1 is linked to metabolic disease.